12:28 PM
Jul 03, 2018
 |  BC Extra  |  Company News

Management tracks: Cigna, Novocure, Voyager

Health services company Cigna Corp. (NYSE:CI) appointed Mark McClellan to its board, effective the earlier of Dec. 1 or the close of Cigna's acquisition of Express Scripts Holding Co. (NASDAQ:ESRX). McClellan is director of the Duke-Margolis Center for Health Policy and a board member at Johnson & Johnson (NYSE:JNJ), where he serves on the Regulatory, Compliance & Government Affairs Committee and the Science, Technology & Sustainability Committee. McClellan was also previously FDA commissioner and administrator of CMS.

Cancer company Novocure Ltd. (NASDAQ:NVCR) named Pritesh Shah chief commercial officer. He was the company’s SVP of the Americas.

Read the full 460 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >